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Biologic scaffolds derived from decellularized tissues and organs have already been successfully 
used in both pre-clinical animal studies and human clinical applications, so more attentions have 
been paid to regenerative and medical applications of decellularized tissues. Here, we report a 
novel way of constructing tissue-engineered conduit by the use of decellularized tissues. For the 
patients who have bladder cancer, they do need a way to pass urine out of their body when they 
have the surgery to remove the diseased bladder. A neo-urinary conduit (NUC) is such a man-
made organ that can work as a passage for urine removal for those patients in bladder cancer. 
Considering the naturally biological compositions and excellent mechanical and structural 
properties, a decellularized trachea must be a fabulous candidate for NUC.  
In this paper, we use the decellularized trachea from rabbit and further estimate its mechanical 
properties and whether it is feasible to grow human smooth muscle cells (hSMCs) and human 
urothelial cells (hUCs) on it. According to the results of mechanical testing, we found that the 
decellularized trachea has ultimate tensile strength (UTS) of 0.34 MPa in longitudinal direction 
and 1.03 MPa in circumferential direction. In addition, the scanning electron microscopy (SEM) 
results show that in the lumen of the scaffold, hUCs grow in a flatten pattern and are 
interconnected with each other, while on the outer surfaces, they are round and spherical. For 
hSMCs, they can penetrate the scaffold and grow anywhere. Also, the results of immunostaining 
and quantitative RT-PCR indicate the hSMCs are able to grow and survive on the scaffold for a 
long time, which provides the possibility of applying the scaffold to the clinical studies. 
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Chapter 1. Introduction 
 
The main goal of tissue engineering in recent years is finding and developing novel and perfect 
materials for neo-organs, including synthetic biodegradable polymers and natural animal tissues 
[1]. With more and more research has been conducted in this field, decellularized tissues have 
attracted a lot of attention as an excellent alternative to make biological scaffolds [2-10]. A lot of 
different decellularized tissues have been studied, including small intestine submucosa (SIS), 
thoracic aorta, bladder, trachea and pericardium. In order to fabricate a tissue-engineered 
scaffold, there are three steps for them: extraction, decellularization and processing [11-15]. 
Compared with synthetic materials, the physical, chemical and biological properties of 
decellularized tissues are more similar to human tissues and therefore it might be easier for 
human cells to grow on them, which is very conducive to tissue remodeling and regeneration 
[16]. Meanwhile, there are a lot of growth factors, extra-cellular matrix (ECM), peptides and 
proteins in decellularized tissues, which is able to facilitate the vascularization. These features 
and advantages make decellularized tissues very suitable for regenerating both orthotopic and 
ectopic tissues [17]. For example, decellularized pericardium and SIS have already been applied 
for the tissue engineering of skin, bowel and bladder [16,17]. To improve the structural integrity 
and enhance the resistance against the enzymatic degradation, crosslinking with some chemicals 
is often opted [18]. Among all those different crosslinkers, “Genipin” is an attractive natural and 
biodegradable crosslinker because of its low cytotoxicity, anti-inflammatory, anti-oxidative and 
anti-thrombotic activities [19-23]. At the same time, the genipin crosslinked decellularized 
tissues can contribute to the proliferation and regeneration of human smooth muscle cells and 
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urothelial cells in vitro conditions and promote the angiogenesis without any pro-inflammatory 
responses, which is very exceptional for tissue-engineered scaffolds [22-26].     
In general, we use decellularized tissues to regenerate the same type of tissues, but we used 
decellularized trachea to fabricate a neo-urinary conduit (NUC). For patients with invasive 
bladder cancer, their bladder is usually diseased and malfunctioning and has to be removed 
surgically. After the surgery, the patients need to use a conduit to pass urine out of their body or 
choose to have a new neobladder. In general, surgeons will use their gastrointestinal tracts to 
make a urinary diversion for patients although it might be detrimental for long-term health of 
patients with causing chronic kidney diseases and urinary tract infection [27-33]. However, to 
some extent, tissue-engineered urinary diversion, challenges associated with using GI tract [34-
38]. Their application in pre-clinical phase has been proved to very successful [39]. However, 
when it comes to clinical phase, the results are not very satisfactory because tissue-engineered 
urinary diversion is not strong and biocompatible enough to function as an ideal neo-urinary 
conduit. In the first clinical phase, tissue-engineered urinary diversion supported the growth of 
human smooth muscle cells and human urothelial cells and regenerate cell layers as proven by 
histology testing. But it has a huge deficiency: it will form an abnormal amount of fibrous tissues 
in vitro and greatly contract and shrink over time without the ability to vascularize [36-39]. 
Based on the discovery mentioned above, we find that utilizing unseeded biological scaffold has 
great potential to regenerate urinary tissues in human body [40-42]. Also, the scaffold can be 
wrapped by the neighboring omentum, which it is likely to support formation of smooth muscle 
cells layers because it can offer excellent biological environment for cells [36,37,43]. 
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Here, we explore the possibility of using decellularized rabbit trachea to act as a neo-urinary 
conduit (NUC) for patients with bladder cancer. By analyzing the inside structure of rabbit 
trachea, it is easy for us to find that there are some small cartilage rings in it, which can provide 
appropriate biomechanical characteristics for the scaffold [44-47]. In addition to sufficient 
mechanical strength, decellularized trachea exhibits the properties of an “ideal biological 
scaffold”, namely biocompatibility, bioabsorbability, nonimmunogenity, support of cell 
attachment and growth, and an ability to induce angiogenesis [26]. We further crosslinked 
decellularized trachea with genipin. It is considered to be a naturally derived cross-linking agent 
and also known to improve the mechanical properties of decellularized tissues. The present study 
aimed to investigate the impact of the decellularization method and crosslinking agent on the 
compositional, structural, and mechanical integrity of rabbit tracheal extracellular matrix and to 










Chapter 2. Materials and Methods 
 
2.1 Decellularization process of rabbit tracheal matrices 
 
The tracheas samples were decellularized using a previously described detergent-enzymatic 
treatment (DEM) [44,48-49]. First, the rabbit tracheae (Pel-Freez Biologicals, Arkansas) were 
washed three times with PBS for 30 minutes in total, and then snap frozen in the liquid nitrogen 
for 5 minutes and thawed at 37°C for 5 minutes, followed by detergent–enzyme decellularization. 
In the detergent step, the tracheas were incubated with 0.25% w/v sodium deoxycholate (Sigma) 
and 0.25% v/v Triton X-100 that are diluted in PBS and rotated continuously for 24 h at 37°C. 
Detergent was then removed and samples were washed in PBS for three times. In the enzyme 
step, DNase-I (150U/mL21; Sigma) and 50 mmol MgCl2 (Sigma) diluted in PBS were used with 
continuous rotation for 24 h at 37°C. When the enzyme step was finished, the tracheae were 
washed with isopropanol for 24 h. And after washing three times (10 min at each) with PBS, the 
trachea samples were stored in PBS containing 1% antibiotic and antimycotic solution at 4 °C 
overnight, and the next cycle was initiated the following day. 
2.2 Biomechanical tests 
 
Both native and decellularized tracheae matrices were tested via the Bose tensile testing 
instrument (Enduratec ELF 3200, 225 N load cell) or the Instron tensile testing instrument (Load 
cell 5 N) to determine their strain characteristics. For this testing, the trachea specimens were 
first cut into small strips of 1.5 to 2.0 cm with width of approximately 5 mm from rabbit bladder 
(n=3). Then the samples were subjected to increasing uniaxial tensile testing until rupture, as 
confirmed by the loss of load and the appearance of tears in the tissue. The specimens were 
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clamped into sample holders, a pre-load (preliminary force) of 1 N was applied and the testing 
was initiated at a constant elongation rate of 0.1 mm/s at room temperature. The tensile tester 
recorded the stress and strain value in real time. Parameters such as tensile strength and linear 
elastic moduli values, along the longitudinal and circumferential (without the muscle tissues that 
joins the ends of the cartilage rings) axes of the sample strips were recorded and calculated using 
Microsoft Excel and Prism 6.0 software programs (Table 1). 
An OMEGA DPG4000-1K digital manometer (OMEGA, Stamford, CT) was used to assess and 
record the compressive properties of each sample in real time. First, the specimen needed to be 
appropriately positioned in the instrument. One end of the sample was attached to a syringe 
pump (New Era Pump Systems, Farmingdale, NY), which was connected to the manometer by 
using a three-way adaptor, while the other end was fixed tightly. Then we used PBS to inflate the 
samples through a syringe pump at the rate of 0.2 mL/s until they were burst and mean burst 
pressure of the samples would be recorded.  
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2.3 Scanning electron microscopy 
 
To qualitatively evaluate the decellularized trachea matrix structure, tracheal (native and 
decellularized) matrices were fixed with 2.5% (v/v) glutaraldehyde(Aladdin, Shanghai, China) in 
the mixture of 100 mM sodium cacodylate buffer and 0.1% tannic acid (pH7.2-7.4) at 4°C. After 
rinsing in a 100 mM sodium cacodylate buffer containing 3% sucrose and 3.0 mM MgCl2, the 
specimens were subjected to post-fixing in 0.8% potassium ferrocyanide and being reduced with 
1% osmium tetroxide for one hour on ice in a dark room. After that, the samples were washed by 
distilled water, followed by ethanol gradient dehydration and hexamethyldisilanaze (HMDS) 
rinsing. When the tracheal specimen were completely dried in a desiccator, they were sputter 
coated with gold and observed by scanning electron microscopy (LEO 1530 FESEM). 
2.4 Preparation of bioengineered scaffold and surface modification 
 
In order to prepare bioengineered scaffold, the decellularized trachea specimen were cut into 
different smaller pieces in a cylindrical shape. The length of small scaffolds is around 7.5 mm. 
We used PBS mixed with 4% ethanol and 0.2% peracetic acid (PAA) to sterilize the scaffolds. 
The whole sterilizing process should last for 6 h. When the sterilization step was completed, we 
continued to wash the tracheal scaffolds with PBS five times, then with isopropanol and kept it 
in isopropanol solution for 24 h. Finally, we wash the scaffolds three times in PBS solution. In 
order to make sure various cells can be attached to the bioengineered scaffold, we tried several 
different ways to modify the surface of the scaffold. Genipin cross-linking treatment: The 
decellularized tracheae were cross-linked in 1% w/v aqueous genipin (Merlin, Hangkong, China) 
solution buffered with PBS and ethanol mixture (70/30) for 4h at 37 °C under constant agitation. 
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After the crosslinking, the color of the decellularized tracheae would become light blue. The 
treated tissues were then thoroughly washed with sterile PBS and peracetic acid, with each 
washing cycle lasting for 10 min. Finally, the light blue color would disappear. Collagen-I 
coating: we kept our tracheal scaffold in collagen-I solution (5 mg/mL in HCl, CosmoBio) and 
then used a piece of tissue paper to absorb the extra collagen-I solution. After that, the scaffold 
was submerged in a neutralizing solution for 5 min, which is made up of 8.8 mL of Dulbecco's 
Modified Eagle's Medium (DMEM) with 1 g/L D-Glucose, L-glutamate, 110 mg/L Sodium 
Pyruvate (Life Technologies, NY), 0.2 mL of HEPES (x1, 1M) and 1.0 mL of fetal bovine serum 
(FBS) [50]. Finally, the scaffold was vitrified in a controlled humidity chamber for 4h at 40% 
RH and 39°C [50-51]. Oxygen-plasma treatment: we put the tracheal scaffold in plasma with a 
pressure of 280-290 mmHg at room temperature for 10 min. The oxygen in the atmosphere could 
help activate free radicals in the surface of the scaffold. After keeping the scaffold in 10 mL 
solution containing 10 % (v/v) polyacrylic acid (PAA) and 0.5 mM NaIO3, we exposed it to UV 
(36 mW/cm2, DYMAX Light Curing Systems 5000 Flood, Torrington, CT) for 2 min to initiate 
the photo-polymerization of PAA to modify the surface of the scaffold. RGD (a cell-integrin 
binding peptide with sequence-Arginine-Glycine-Aspartic acid) treatment: we soaked the 
scaffold in NHS-PEG-MAL solution (3.4 kDa, JenKem) at a concentration of 1 mg/mL and put 
them in a shaker for half an hour. Then we transferred the scaffold to the RGD solution (1 
mg/mL, Biomatik), put them in a shaker for 2h and finally wash with PBS for one time.  
2.5 Establishment of Smooth Muscle and Urothelial cell lines  
 
We purchased both human smooth muscle cells (hSMCs) and urothelial cells (hUCs) from the 
ScienCell Research Laboratories (Carlsbad, CA). Human smooth muscle cells were grown in 
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Dulbecco's modified Eagle's medium (DMEM) and Ham's F-12 nutrient mixture (3:1) (Sigma), 
containing L-Glutamine, 15 mM HEPES and 1.0 ng/ml basic FGF (Life Technologies, Grand 
Island, NY) supplemented with 10% fetal bovine serum (FBS) and 1% Penicillin/Streptomycin. 
We started counting passage number when we were first able to pass the cells into 35-mm plates 
(passage 1). The hSMCs were harvested at passage 3. Urothelial cells were seeded in a growth 
media consisting of basal UC medium (Sciencell, CA) and UC growth factor supplemented with 
1% Penicillin/Streptomycin (Life Technologies). The hUCs were harvested at passage 4. Two to 
three days later, both hSMCs and hUCs needed to be transferred into new wells. All the cells 
must be cultured in in a humid environment at 37°C and 5% CO2. 
2.6 Growth of hSMCs and hUCs in the surface of tracheal scaffold  
 
We disaggregated the hSMCs at passage 4 using trypsin (0.25%, 5 mL per tissue culture plate) 
and centrifuged them at 1,000 rpm for 5 min. Then we seeded the detached cells in hSMCs 
growth medium to increase the cell density to approximately 2 million cells/ml. After that, we 
transferred the bioengineered scaffold and hSMCs growth media to a cryotube (Nunc, 3.6 mL), 
and then put it inside a centrifuge tube (15 mL, Becton Dickinson), followed by shaking for 6h at 
37°C until the cell density reached 2 million cells per scaffold (length of 0.75 cm). Finally, we 
took the scaffold out and put in non-tissue culture well plates to keep growing hSMCs for one 
week. After seven days, we transferred the tracheal scaffold seeded with hSMCs to small cut 
pipette tips (1 mL, ThermoFisher). One end of the small cut pipette tips was sealed by parafilm, 
while on the other end, we tried to grow hUCs at passage 4 on the inner lumen of the tracheal 
scaffold. Then the small cut pipette tips were kept in cryotubes, which had already been put 
inside centrifuge tubes previously. They had to be shaken continuously for 4h at 37°C. After 4h, 
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we took out the scaffold and kept it in 12 well-tissue culture plates filled with both hSMCs 
growth medium and hUCs growth medium (50/50).  All the cells must be cultured in in a humid 
environment at 37°C and 5% CO2. For the study of cell morphology, cells should be cultured in 
shorter time and the bioengineered scaffold needed to be cut into several small rings (3 mm x 3 
mm). The scaffold could be cultured with either hSMCs (75,000 cells per scaffold) or hUCs 




Immunostaining consists of two parts: immunofluorescence staining (IF) and 
immunohistochemistry (IHC) [52]. For immunofluorescence staining, we cut the trachea samples 
embedded in paraffin into smaller sections at a 5 μm thickness with a Cryo-mill (Leica), then 
submerged them in a 40°C water bath for some time and finally put all the samples into glass 
microscope slides. These glass microscope slides had to be left at 40°C overnight. In order to get 
rid of paraffin and hydrate the samples, we first washed the sections with xylene and then graded 
alcohol (100%, 95%, 80%) and eventually with distilled water. Pretreatment of sections with 
microwave heating for 45 minutes in a target retrieval solution (Dako, CA) was used for antigen 
retrieval. After heating, sections must be cooled until room temperature for further steps. These 
sections were covered with serum-free protein blocking buffer (Dako code X0909) to reduce 
nonspecific staining for 1h at 37°C in a dark chamber and then immunostained overnight at 4°C 
with primary antibody (alpha-smooth muscle actin and pan cytokeratin, Abcam). After washing 
with a Dako wash buffer for 5 min, the sections were incubated with secondary antibodies and 
then covered with a 1:800 dilution of streptavidin peroxidase complex at room temperature for 
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2h, followed by the same Dako wash buffer rinsing for 5 min. When we finished the incubation 
of secondary antibodies, all the sections were washed in distilled water, dehydrated in graded 
alcohol (80%, 95%, 100%) and xylene, and mounted with a Permount mounting solution on a 
cover slip. Sections were also stained with 40-6-diamidino-2-phenylindole (DAPI; KeyGEN, 
Nanjing, China) to detect nuclear material. All stained sections were evaluated by 2 pathologists 
independently and graded as score 1-negative to few cells positive (less than 5% cells), score 2-
heterogeneously positive (range 5% to 80%) and score 3-uniformly positive (greater than 80%), 
as reported previously [53]. 
For immunohistochemistry, trachea samples (native and decellularized) were fixed for 24 h in 10% 
neutral buffered formalin solution in PBS (pH 7.4) at room temperature. After fixation, the 
samples were rinsed in distilled water, dehydrated in graded alcohol, embedded in paraffin, and 
sectioned at 6 µm thickness. In order to remove paraffin, rehydrate the samples and retrieve 
antigen, we soaked the samples in in Trilogy (Cell Marque, AR) in a pressure cooker at 126oC 
under the pressure of 23 psi. Then we blocked endogenous Peroxidase and Alkaline Phosphatase 
using a Dual Endogenous Block (DAKO North America Inc., CA). Sections were incubated at 
4oC for 45 min with rabbit primary antibodies (cleaved caspase 3, Cell Signaling Technology, 
MA; vimentin, Cell Signaling Technology, MA; Ki67, Abcam, MA; alpha-smooth muscle actin, 
Abcam, MA). After washing, PowerVision Poly-HRP anti-Rabbit IgG (Leica Biosystems, IL) as 
secondary antibody was applied for 30 min. We detected the antibody complex with 
diaminobenzidine (DAB), which is the color substrate of horseradish peroxidase (HRP). 
Eventually, these sections were counterstained with hematoxylin (Richard-Allen Scientific, 
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Kalamazoo, MI), mounted and then examined under Zeiss Discovery V2 dissection imaging 
microscope. 
2.8 Gene expression by quantitative real-time polymerase chain reaction 
 
In this part, we examine the gene expression of different cells by using a quantitative real-time 
polymerase chain reaction (qRT-PCR) [52]. For sample preparation, we collected the fresh 
samples at various time points. After that, all the biological specimen were instantly shock-
frozen in liquid nitrogen and stored at -80°C until further use. For RNA extraction and 
complimentary cDNA synthesis, we thawed the frozen samples and adapted the protocol from 
RNeasy mini kit (Qiagen, CA) to permit the isolation of total RNA from those specimens. After 
RNA extraction, the total RNA (300 ng) was then transcribed to cDNA by using random 
hexamers and Ready-To-Go You-Prime First-Strand Beads (GE healthcare, PA) serving as 
primers in a total volume of 20 µL. We put the mixed solution in a 96 well plate and ran the PCR 
reaction in triplicates. mRNA encoding for β-actin or glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) was processed as used as a housekeeping gene. Its product served as 
the control for RNA and relative quantification. For the real-time quantitative RT-PCR, it is 
carried out on an Applied BioSystems 7900HT thermocycler (Applied Biosystems, Inc.) using 
the following conditions: 50 °C for 2 min and 95 °C for 10 min, followed by 40 cycles of 95 °C 
for 15 s and 60 °C for 1 min. Raw data can then be analyzed with SDS Relative Quantification 
Software version 2.2.3 (Applied BioSystems, Inc.), generally using the automatic cycle threshold 
(Ct) setting for assigning baseline and threshold for Ct determination. Finally, we used the probe 
TaqManR Universal Mix II, No UNG (Thermofisher, MA) to detect the expression of following 
genes (Table 2): Smooth-muscle alpha-actin (ACTA2), Transgelin (TAGLN), smooth muscle 
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myosin heavy chain (MYH11), smooth muscle basic (h1) calponin (CNN), Myocardin (MYOCD), 
smoothelin (SMTN), non-muscle myosin heavy chain B (MYH10), cellular-retinol binding 
protein-1 (RBP1) vimentin (VIM), collagen-I alpha1 (COL1), collagen-III alpha1 (COL3), elastin 
(ELN), laminin (LAMA1), cytokeratin 5 (KRT 5), cytokeratin 18 (KRT18), uroplakin 3 (UPK3A), 
caspase 3 (CASP3) and S100 calcium-binding protein A4 (S100A4). 
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2.9 Statistical analysis 
 
All quantitative data are expressed as the mean ± standard deviation of three separate 
experiments. Statistical analysis was performed by unpaired t-test with Welch’s correction for 
post-hoc comparisons. Differences were considered significant at the 95% level (p < 0.05). 















Chapter 3. Results 
 
3.1 Characterization of decellularized rabbit tracheal matrix 
 
The decellularized trachea retained the typical gross anatomical structure of native trachea, 
compared to freshly harvested tissues (Figure 1A and 1B). After decellularization, the three-
dimensional architecture and composition of the tracheal matrix remained intact and were 
virtually unaltered, including the preservation of the lumen, middle cartilage and outer layers. 
And quantitative analysis of histologic sections revealed that DNA concentration in the tissue 
was substantially decreased from 1716±76 ng/mg in native trachea to 163±54 ng/mg after 
decellularization (Fig. 1C). Nuclei stained with hematoxylin and eosin (H&E) were almost 
completely removed in the noncartilaginous tissue, and only a small number of nuclei remained 
in the thick cartilage (Fig. 1D and 1E). Safranin-O staining showed that glycosaminoglycan 
(GAG) expression was mainly concentrated to the cartilaginous region. After decellularization, 
there was a significant loss of glycosaminoglycan in the outer layer of the tracheal cartilage (Fig. 
1F and 1G). Masson’s trichrome staining (Fig. 1H and 1I) showed that only the connective 
tissues (blue) and some cell nuclei (dark red) could be stained in the decellularized scaffold, 
while cytoplasm (pink) can be stained in native trachea. 
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Figure 1. Characterization of decellularized rabbit tracheal matrix. The native trachea (A), 
after detergent-enzymatic treatment (B). DNA content (C), hematoxylin and eosin (H&E) 
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staining (D&E), Safranin-O staining (F&G) and Masson’s trichrome staining (H&I) of the 
tracheal scaffold before and after decellularization. (** denotes statistical significant values with 
p < 0.05) This figure is reproduced with the permission from the publisher [70]. 
3.2 Viscoelastic properties of the bioengineered tracheal scaffold 
 
Uniaxial tensile tests were carried out on the decellularized tracheal matrices, showing that the 
bioengineered scaffold can be a good option for constructing a neo-urinary conduit (NUC) with a 
combination of perfect flexibility and tensile strength. The tensile tests were performed in both 
longitudinal and circumferential direction and the related results were characterized by slope-
changing J-curves (Fig. 2A, 2B). The ultimate tensile strength (UTS) was the maximum stress at 
the reversal point of the engineering stress–strain curve and the initial linear elastic modulus 
(LEM) was measured within the linear region of initial 0% to 10% strain. In Table 1, we find in 
longitudinal direction, both UTS and LEM values significantly decreased in the decellularized 
trachea compared with the native tracheal matrices (UTS: native vs decellularized scaffolds: 
0.62±0.09 MPa vs 0.34±0.07 MPa; LEM: native vs decellularized scaffolds: 0.29±0.07 MPa vs 
0.06±0.02 MPa). In circumferential direction, there was a similar decrease in UTS and LEM 
(UTS: native vs decellularized scaffolds: 1.92±0.20 MPa vs 1.03±0.30 MPa; LEM: native vs 
decellularized scaffolds: 6.07±1.30 MPa vs 3.11±1.80 MPa). For the UTS of genipin- crosslinked 
samples, there was an increase in longitudinal direction (from 0.34±0.07 MPa to 0.55±0.10 MPa), 
but a slight decrease in circumferential direction (from 1.03±0.30 MPa to 0.85±0.20 MPa). And 
for LEM values, there was an increase in both two directions (longitudinal direction: from 
0.06±0.02 MPa to 0.35±0.05 MPa; circumferential direction: from 3.11±1.80 MPa to 3.75±0.50 
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MPa). We also used rabbit bladder strips as a control (Fig. 2H) with the UTS of 0.20±0.06 MPa, 
LEM of 0.05±0.01 MPa and ultimate tensile strain of 330%.  
Figure 2. Mechanical characteristics of native vs. bioengineered tracheal scaffolds. The 
tensile tests were performed in both longitudinal and circumferential direction (A). Stress-strain 
curves (B), initial linear elastic modulus (LEM) (C), the ultimate tensile strength (UTS) (D) of 
the native and decellularized scaffolds in longitudinal direction. Similarly, we got the stress-
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strain curves (E), LEM (F) and UTS (G) results in circumferential direction. We also used a 
rabbit bladder as control and got its stress-strain curve (H). This figure is reproduced with the 
permission from the publisher [70]. 
3.3 Cell attachment on surface-modified decellularized trachea 
 
In order to improve the cell adhesion on the decellularized scaffold, we tried several different 
ways to modify the surface of the scaffold: oxygen-plasma treatment, collagen-I coating and 
RGD (a cell-integrin binding peptide with sequence-Arginine-Glycine-Aspartic acid) treatment 
(Fig. 3A-D). For RGD treatment and collagen-I coating, human smooth muscle cells (hSMCs) 
were able to grow on the modified surface of the scaffold and the decellularized tracheal 
maintained a sufficient extracellular matrix and structural rigidity. For oxygen-plasma treatment, 
it caused some changes in the structure of the decellularized scaffold. However, these modified 
surfaces cannot provide the scaffold with a consistent and sufficient cell adhesion, so we had to 
get rid of hydrophobic or lipid components from native trachea in the process of decellularization 
to enhance cell attachment. 
Figure 3. Decellularized tracheal scaffold with modified surfaces. In order to improve cell 
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attachment of the decellularized scaffold (A), we tried several different ways to modify the 
surface of the scaffold: oxygen-plasma treatment (B), RGD (a cell-integrin binding peptide with 
sequence-Arginine-Glycine-Aspartic acid) treatment (C) and collagen-I coating (D). (scale bar = 
200 µm for 100X, and = 100 µm for 200X) This figure is reproduced with the permission from 
the publisher [70]. 
3.4 Morphological study of human urothelial cells and smooth muscle cells on the 
scaffolds 
 
Cell morphologies on the decellularized tracheal scaffolds in different condition were examined 
by scanning electron microscopy (SEM). For the trachea without crosslinking, there is a clear 
boundary between the luminal and outer surfaces (Fig. 4A). And the lumen has a lot of smaller 
and finer fibers and thereby exhibits a smooth surface, while the outer surface possesses thicker 
and bigger fibers and shows a much rougher surface. For the genipin-crosslinked trachea, we can 
observe the same morphologies, but they are more apparent and obvious. When we grow the 
human urothelial cells (hUCs) on the decellularized tracheal scaffold, hUCs are able to grow in 
the lumen, outer surface, edge and cartilage rings of the trachea (Fig. 4B). In the lumen, the 
urothelial cells are tightly arranged and form a uniform pattern (denoted by arrow marks). In the 
outer surface, the cells are more separate and in a spherical shape, which means they are not 
proliferating well. At the edges, there is a distinct boundary between lumen and the outer surface 
so that we can observe the cell morphologies of both two areas more clearly. In the cartilage ring, 
the cells are surprisingly growing and spreading better than muscle regions. Also, for the 
crosslinked trachea seeded with the hUCs, there is not a huge difference in the cell morphologies 
of lumen, outer surface, edge and cartilage ring. 
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For the decellularized trachea scaffold seeded with human smooth muscle cells (hSMCs), 
hSMCs are growing in the shape of an elongated spindle and adopt a very similar arranging 
pattern in the lumen, outer surface and edges of the scaffold (Fig. 4C). For the genipin-
crosslinked one, hSMCs are proliferating better and organizing themselves more densely on all 
the three surfaces.  
For the decellularized trachea scaffold seeded with both hSMCs and hUCs in a mixed cell 
culture medium (hSMCs growth medium/ hUCs growth medium: 50/50), the morphological 
behavior of hSMCs and hUCs is a little similar ((Fig. 4D). For hSMCs, they are spreading and 
growing overwhelmingly in the lumen, outer surface, edge and cartilage rings of the tracheal 
scaffold. But compared with hSMCs cultured in only hSMCs growth medium, they are in a 
shorter-spindle shape and appear to have more protrusions. For hUCs, they are able to grow and 
proliferate in the lumen, edge and cartilage rings of the tracheal scaffold, but unable to spread 
and grow on the outer surface. Under the mixed cell culture condition, hUCs are round and 
compact and show tight cell-to-cell contacts, which is similar to those grown in only hUCs 
growth medium. And for the genipin-crosslinked trachea seeded with both hUCs and hSMCs, we 
do not observe many different cell morphologies in the lumen, outer surface, edge and cartilage 
rings of the scaffold. 
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Figure 4. Morphologies of human urothelial cells and smooth muscle cells on the 
decellularized and genipin-crosslinked scaffolds. The fiber morphologies of lumen, outer 
surface and edge in the decellularized tracheal scaffold (control without crosslinking) (T) and in 
the genipin-crosslinked scaffold (TG) were examined by SEM (A). After we seed the 
decellularized tracheal scaffold with human urothelial cells (hUCs), hUCs are able to grow in the 
lumen and cartilage rings of the trachea, but prefer the luminal surface with uniform and tight 
cell arrangement for both T and TG (B). In contrast, hSMCs can spread and proliferate in all the 
surfaces of the decellularized scaffold with the shape of an elongated spindle. Genipin-
crosslinking seems to promote the growth of hSMCs (C). For the decellularized trachea scaffold 
seeded with both hSMCs and hUCs in a mixed cell culture condition, hSMCs are spreading and 
growing overwhelmingly in the lumen, outer surface, edge and cartilage rings of the scaffold, 
while hUCs still prefer growing in the lumen (D). (scale bar = 100 µm for 100X, 200 µm for 
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300X and 10 µm for 600X) This figure is reproduced with the permission from the publisher 
[70]. 
3.5 Biomechanical properties of the cell-seeded decellularized trachea 
 
In order to know whether the cell culture on the surface of the scaffold would influence its 
biomechanical properties, we compare the uniaxial tensile testing results of the cell-seeded 
decellularized trachea with that of the decellularized trachea. According to Fig. 5A and Table 1, 
we discovered that in longitudinal direction, there was a slight increase in UTS values after cell 
seeding (from 0.34±0.07 MPa to 0.42±0.08 MPa), but a decrease in ultimate tensile strain (from 
55% to 45%). And in circumferential direction, there was a decline in the values of both UTS 
and ultimate tensile strain after the growth of various cells (UTS: from 1.03±0.30 MPa to 
0.80±0.13 MPa; ultimate tensile strain: from 75% to 40%). 
3.6 Immunostaining 
 
For immunofluorescence staining, pan-cytokeratin is a cytoskeleton marker for human urothelial 
cells (hUCs), while alpha-smooth muscle actin is a special marker for human smooth muscle 
cells (hSMCs). With the use of 40-6-diamidino-2-phenylindole (DAPI; KeyGEN, Nanjing, 
China), we can detect the nuclei in various cells, which is blue in Fig. 5B. Also, for the tracheal 
scaffolds grown with both hSMCs and hUCs for only three days, we can easily find out the 
existence of pan-cytokeratin (red) in Fig. 5B, while there is no red for the scaffolds seeded with 
both cells for a week. And for hSMCs, we can find out the positive staining for alpha-smooth 
muscle actin (green) in both three days and one-week cell-cultured scaffolds. 
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For immunohistochemistry, alpha-smooth muscle actin (SMA) is a contractile phenotype marker 
for hSMCs, while vimentin is a synthetic phenotype marker for hSMCs; Ki67 is a cellular 
marker for proliferation; cleaved caspase 3 is a marker related to cellular apoptosis. In Fig. 5C, 
we can discover the existence of SMA and vimentin in some vessel-like structures (marked in 
dotted circles). Meanwhile, we also observe the positive staining of Ki67 and cleaved caspase 3, 
which means some cells are undergoing proliferation and apoptosis, respectively.  
3.7 Gene expression 
 
For the genipin-crosslinked scaffold seeded with both human smooth muscle cells (hSMCs) and 
human urothelial cells (hUCs), the level of gene expressions for different cells were evaluated by 
quantitative real-time polymerase chain reaction (RT-qPCR). According to Fig. 5D, we observed 
that the gene expression level of ACTA-2 (2 folds), TAGLN or SM 22-alpha (8 folds), CNN1 (6 
folds), MYOCD (1.7 folds), MYH10 (3 folds), RBP1 (2.3 folds), VIM (2.5 folds), ELN (9 folds) 
and CASP3 (2 folds) were upregulated significantly, while MYH11, SMTN, COL 3 were only 
increased slightly. For COL 1 and S100A4, although there was a decrease at the beginning stage, 
their gene expression levels were ultimately increased in week four. Besides that, LAMA1 (11 
folds) and KRT 5 (12 folds) were downregulated, while UPK3A was not detected through one 
week to four weeks. Furthermore, the genes with increased values of expression are the markers 
of hSMCs, which confirmed the existence of smooth muscle cells, while the undetected gene and 
the genes with decreased values of expression are the markers of hUCs, which means the 
disappearance of urothelial cells. 
26 
 
Figure 5. Immunostaining and gene expression for both hSMCs and hUCs. The stress-strain 
curves reveal that cell seeding and genipin-crosslinking can help improve the mechanical 
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properties of the decellularized tracheal scaffold (A). We performed the immunofluorescence 
staining (IF) for the decellularized tracheal scaffold seeded with cells for three days and one 
week and pan-cytokeratin (red), alpha-smooth muscle actin (green) and nuclei (blue) were 
stained (B). We also did immunohistochemistry (IHC) for the tracheal scaffold and found out the 
presence of hSMCs markers for both contractile and synthetic phenotype (SMA and vimentin). 
We also observe the proliferation (Ki67) and apoptosis (cleaved caspase 3) of various cells (C). 
The results of gene expression showed that the genetic markers for hSMCs were upregulated 
over time, while the genetic markers for hUCs were downregulated or not detected (D). Cleaved 
caspase 3 and S100A4 are the hSMCs markers for apoptosis and fibrosis, respectively. LAMA, 
KRT5 and UPK3 are the genetic markers of hUCs and UPK3 is only present on the layer of 











Chapter 4. Discussion 
 
Tissue engineering provides a promising approach for constructing a neo-urinary conduit (NUC). 
The selection of the most reasonable bioengineered scaffold is highly important for a suitable 
engineering process and subsequent in situ organ function. As an ideal scaffold, it should mimic 
the target tissue environment and maintain the required tissue-specific mechanical properties. 
Various natural and synthetic materials have been applied to trachea tissue engineering, 
including poly(glycol acid), poly(lactic acid), collagen, hyaluronic-acid, and chitosan [54-57]. 
Although good mechanical stability and cell growth have been obtained in some cases, these 
constructs are far from translation into clinical applications because their functionality, 
biomechanics, viability, and adequate and continuous vascularization remain undetermined. 
However,  decellularized tissue currently appears to be the most promising approach to obtaining 
suitable scaffolds to engineer a variety of tissues and organs, not only because they have a 
mechanic function but also because they can affect cell proliferation, migration, differentiation 
and, as a consequence, tissue regeneration and remodeling. Various detergents and solutions and 
physical techniques have been used to obtain such a scaffold [58]. Most of them have been found 
to be highly efficient at removing cellular materials but also caused disruption of 
glycosaminglycan (GAG) and substantially reduced laminin and fibronectin ECM content, 
thereby compromising the ability of the scaffolds to provide mechanical support during the 
remodeling process [59]. In this paper, we used a detergent enzymatic approach (DEM) based on 
the use of deoxycholate and DNase, which is the only clinically acceptable method for producing 
a decellularized trachea. Using DEM, the three-dimensional architecture and composition of the 
tracheal matrix remained intact and was virtually unaltered, including the preservation of the 
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lumen, middle cartilage and outer layers. In Fig. 1D and Fig. 1E, the nuclei were effectively 
dissolved by DNase and removed from the luminal and outer layers. The DEM, however, has 
different effects on non-cartilaginous tissues and cartilage. It is highly efficient at removing cells 
from the non-cartilaginous tissues, but not from cartilage and that is the reason why there are a 
small number of nuclei remained in the deep cartilage. In addition, the decellularization process 
will affect the composition and structure of the extracellular matrix. Glycosaminoglycan (GAG) 
is the main substance of the native tracheal cartilage, and it is able to provide the trachea with 
sufficient mechanical strength to resist compressive forces. In Fig. 1F and Fig. 1G, we observed 
a loss of glycosaminoglycan content in tracheal cartilage, which is confirmed by the decrease of 
a dark red-brownish staining in the pictures [44,58-60]. 
Uniaxial tensile tests were carried out on the decellularized tracheal matrices, so that we can 
know whether the decellularization process will affect the biomechanical properties of the 
bioengineered scaffold ((Fig. 2A-H & Table 1). The tensile tests were performed in both 
longitudinal and circumferential direction and the related results could be characterized by slope-
changing J-curves due to the structural and compositional anisotropy of various biological tissues. 
For rabbit trachea, it is composed of stiff cartilage rings and compliant soft muscle regions, 
which is responsible for the anisotropy of trachea. For the pull in longitudinal direction, the 
muscle tissues will first be stretched and then the cartilage rings will start to take part in the 
tensile testing and be pulled afterwards. In the stress-strain curves of both native and 
decellularized tracheal scaffolds: from 0 to 20% (strain coordinate), the slope of the J-curve is 
very small, which means the scaffold can be easily pulled and elongated because of the only 
participation of muscle tissues; from 20% to 80%, the slope of the J-curve is very high, 
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suggesting that the scaffold is able to withstand more applied forces due to the participation of 
both muscle tissues and cartilage rings. For the pull in circumferential direction, both muscle 
tissues and cartilage ring will take part in the tensile testing and resist the applied force at the 
very beginning. This can explain the fact that the ultimate tensile strength (UTS) and linear 
elastic modulus (LEM) values of both native and decellularized scaffolds in in circumferential 
direction are higher than those in longitudinal direction.  
In addition, we observe that in longitudinal direction, there is a significant decrease in values of 
LEM and UTS after the DEM decellularization process, while there is an increase for the value 
of ultimate tensile strain (UTS: native vs decellularized scaffolds: 0.62±0.09 MPa vs 0.34±0.07 
MPa; LEM: native vs decellularized scaffolds: 0.29±0.07 MPa vs 0.06±0.02 MPa; ultimate 
tensile strain: native vs decellularized scaffolds: 40% vs 55%). And the increase of the strain 
values of the decellularized scaffold represents the increase of compliance (change in dimension 
per unit stress) of the scaffold. In circumferential direction, there is a similar decrease in UTS 
and LEM, while an increase in the value of ultimate tensile strain after decellularization (UTS: 
native vs decellularized scaffolds: 1.92±0.20 MPa vs 1.03±0.30 MPa; LEM: native vs 
decellularized scaffolds: 6.07±1.30 MPa vs 3.11±1.80 MPa; ultimate tensile strain: native vs 
decellularized scaffolds: 40% vs 75%). The change of the values of LEM, UTS and ultimate 
tensile strain can be attributed to the loss of cellular elements and glycosaminoglycan (GAG) 
[26,36]. When we increase the volume compliance (change in storage volume capacity to initial 
storage volume capacity) of the decellularized scaffold to three times, we discover it can 
maintain the complete matrix structure under the radial burst pressure of 155 Hg. But if we 
increase the value of pressure, it will burst and start leaking water from inside.  
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In order to improve the stability and mechanical response of tissue-engineered tracheal scaffolds, 
we tried to crosslink the decellularized tracheal scaffold with genipin. Genipin is completely 
naturally derived (it is obtained from geniposide, isolated from the fruits of gardeniajasminoides) 
and can react spontaneously with amino acids or proteins, inducing an intramolecular and 
intermolecular cross-linking cyclic structure within collagen fibers. For tissue-engineering, 
genipin has been shown to be effective in improving the stability of collagen-based biomaterials, 
forming stable cross-linked products with less in vitro cytotoxicity and a lower in vivo 
inflammatory response [19-25,61]. Also, it has been proved that the genipin-crosslinked 
decellularized scaffold can persist in vivo without being subjected to host enzymatic degradation 
[62,63]. However, for a harsher urine-containing environment, there are still a lot of details that 
need to be investigated. 
In summary, the uniaxial tensile testing results reveal that there was a reduction in the 
mechanical performance for the tracheal scaffold after decellularization compared to native 
tracheal matrices, which can be explained by a significant loss of glycosaminoglycan content in 
tracheal cartilage during the decellularization process (Fig. 2B-G). For the cell-seeded scaffold, 
hSMCs spread and proliferated on the outer surface of the scaffold and were not able to penetrate 
into the cartilage ring.  
In order to make different cells able to adhere to the decellularized tracheal scaffold, we tried 
several different methods to modify the surface of the scaffold: oxygen-plasma treatment, 
collagen-I coating and RGD (a cell-integrin binding peptide with sequence-Arginine-Glycine-
Aspartic acid) treatment. For RGD treatment and collagen-I coating, the modified surfaces of the 
decellularized tracheal scaffolds were able to allow the attachment and proliferation of human 
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smooth muscle cells (hSMCs), without altering the internal structure of the matrix. For oxygen-
plasma treatment, it became much stiffer than normal decellularized tracheal scaffolds, which 
was because of the possible internal crosslinking of some functional moieties in the tracheal 
scaffold. However, the abovementioned methods failed to provide the decellularized scaffold 
with a consistent and sufficient cell adhesion, so we chose to get rid of hydrophobic or lipid 
components in the process of decellularization, which are likely to influence the attachment and 
growth of smooth muscle cells [64]. Herein, we tried to wash the decellularized tracheal scaffold 
with isopropanol [65], so that we could remove any visible hydrophobic or lipid components 
from the decellularized trachea and finally achieved perfect and sufficient consistency in cell 
attachment.  
For the morphological study of human urothelial cells (hUCs) and human smooth muscle cells 
(hSMCs), we harvested the cells at an early time point (24 h post seeding) and observed them by 
scanning electron microscopy (SEM). For the decellularized tracheal scaffold and the genipin-
crosslinked one, hSMCs are able to attach and grow in the lumen, outer surface and edges of the 
tracheal scaffold (Fig. 4C). Compared with hSMCs, hUCs prefer spreading and growing in the 
lumen of the decellularized scaffold. On the outer surface, hUCs are spherical and contracted, 
which means they are not proliferating well (Fig. 4B). This can be explained by the fact that 
hUCs like to spread and grow on an intact luminal basement membrane, which fulfills many 
biological functions, including acting as a permeability barrier, influencing cellular behavior and 
differentiation via outside-in signaling, controlling cellular organization and tissue function, and 
providing structural support [66]. But for the outer surface, there are plenty of muscles without 
any biological constituents like collagen IV and laminin [67]. In addition, in the cartilage ring, 
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the cells are growing and spreading better than muscle regions, which is because the main 
components of the tracheal cartilage are glycosaminoglycans (GAG) and collagen that are 
necessary for cell attachment and repopulation. Based on the above observation, we imply that 
no matter where the hUCs are cultured, they will always prefer growing and proliferating on the 
luminal surface of the scaffold. For the decellularized trachea scaffold seeded with both hSMCs 
and hUCs in a mixed cell culture medium (hSMCs growth medium/ hUCs growth medium: 
50/50), hSMCs are spreading and growing overwhelmingly in the lumen, outer surface, edge and 
cartilage rings of the tracheal scaffold, while hUCs are only able to grow in the lumen and 
cartilage rings of the scaffold and still prefer the luminal surface (Fig. 4D). Instead of seeding 
both hSMCs and hUCs in a mixed cell culture medium together, we suggest that the hSMCs 
should be seeded on the outer surface of the scaffold with only hSMCs growth medium and 
when they are able to penetrate into the tracheal scaffold, we start growing hUCs in the lumen 
with only hUCs growth medium. 
In a mixed cell culture medium (hSMCs growth medium/ hUCs growth medium: 50/50), we also 
tried to seed both hUCs and hSMCs on the decellularized tracheal scaffold for four weeks. 
Although hSMCs are able to spread and proliferate overwhelmingly on various parts of the 
tracheal scaffold, the growth of hUCs declined over time, regardless of genipin-crosslinking. For 
immunofluorescence staining, pan-cytokeratin is a cytoskeleton marker for hUCs, while alpha-
smooth muscle actin is a specific marker for hSMCs. Pan-cytokeratin is stained red for the 
decellularized tracheal scaffold seeded with both two cells for only three days, while there is no 
red staining for the scaffold after a week (Fig. 5B). As for alpha-smooth muscle actin (SMA), 
there is a positive staining (red) for the cell-seeded tracheal scaffold from three days to a week. 
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Also, we failed to grow hUCs on the outer surface of the decellularized scaffold in a mixed cell 
culture medium, even if we increased the time to four weeks, suggesting that hUCs are unable to 
attach to the tracheal scaffold filled with hSMCs and they might be removed after the first 
change of culture media. hUCs won’t grow well in vitro and is a main challenge and limitation 
that many other investigators have encountered before, which will prevent a lot of further 
comprehensive experiments [42]. More studies need to be conducted to find out the mechanism 
behind this. For immunohistochemistry, SMA is a contractile phenotype marker; vimentin is a 
synthetic phenotype marker; Ki67 is a cellular marker for proliferation and cleaved caspase 3 is a 
marker related to cellular apoptosis. The staining of SMA and vimentin is positive in some 
vessel-like structures, due to the presence of some biochemical components in the decellularized 
tracheal scaffold (Fig. 5C, dotted circles). In addition, the positive staining of Ki67 and cleaved 
caspase 3 is observed, suggesting the proliferation and apoptosis of various cells. And for the 
NUC construction in vivo, since the decellularized tracheal scaffold with or without cell seeding 
might behave differently in vivo, more investigation is needed.  
With quantitative real-time polymerase chain reaction (qRT-PCR), the level of gene expression 
for both human smooth muscle cells (hSMCs) and human urothelial cells (hUCs) were evaluated. 
According to Fig. 5D, we observe that the expression levels of some genes were upregulated, 
while some gene expressions were downregulated or not detected through one week to four 
weeks. The genes with increased values of expression are the markers of hSMCs, while the 
undetected gene and the genes with decreased values of expression are the genetic markers of 
hUCs. Specifically, the gene expression levels of the contractile phenotype marker (SMA) and 
synthetic phenotype marker (vimentin) for hSMCs were increased over time [68], which 
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confirmed the existence of hSMCs and revealed the decellularized tracheal scaffold was able to 
support the growth and proliferation of hSMCs in vitro. However, the growth of hSMCs in vitro 
dwindled with time, which limited our current investigation. We may need more investigations 
















Chapter 5. Conclusion 
 
In conclusion, the decellularized tracheal scaffold can be a viable alternative for constructing a 
neo-urinary conduit (NUC) with a combination of perfect structural flexibility and sufficient 
mechanical strength. In pre-clinical and clinical studies, decellularized porcine or cadaveric 
human tracheae are more often used because of their appropriate size and dimension. In the 
future, we plan to implant the decellularized tracheal scaffold with and without cell seeding into 
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Master of Chemical and Biomolecular Engineering                                                             Aug. 2016-May. 2018 
Research Experience 
School of Chemical Engineering and Technology  
Key Laboratory for Green Chemical Technology of Ministry of Education                   Apr. 2014-Jun. 2015 
Advisor: Prof. Zhongyi Jiang      
Project 1: Study on the Separation Properties and Interfacial Interactions Manipulation of Composite 
Membranes via a Mussel-inspired Approach(Graduation Project)  
Innovation Point: to present an efficient and facile mussel- inspired approach fortailoring the membrane 
structure for an enhanced separation performance. 
Workload: 
✓ Prepared the ultrathin SA/PEI–PDA/PAN composition membrane by co-depositing biomimetic adhesive 
dopamine(DA) and polyethyleneimine (PEI) on the polyacrylonitrile (PAN) support layer and then 
coating with sodium alginate (SA) as the separation layer. 
✓ Investigated the influence of the mass ratio of PEI and dopamine, reaction time, the concentration of raw 
material solution and temperature on the separation properties of composite membranes.  
✓ Characterized the physical and chemical properties and structures of as-fabricated composition 
membranes by FESEM, FTIR, elemental analyzer, zeta-potential analyzer and contact angle goniometer, 
and evaluated the separation performance of composite membranes by utilizing the pervaporation 
dehydration of an aqueous ethanol solution as a model system. 
Conclusion: The highest separation factor of the SA/PEI–PDA/PAN membranes for water/ethanol separation 
reaches 1807, which is 29.6 and 6.8 fold higher than those of SA/PAN and SA/PDA/PAN membranes, 
respectively. 
Project 2: Fabrication of Layer-by-layer Self-assembly Ultrathin Hybrid Membrane for Pervaporation 
Dehydration 
✓ Prepared graphene oxide (GO) dispersion following the modified Hummers methods and then 
characterized thephysical and chemical structures of GO by TEM, AFM, FT-IR and XRD.  
✓ Fabricated the GO-based ultrathin hybrid multilayer membranes via layer-by-layer self-assembly of GE 
and GO on H-PAN membranes driven by multiple interactions by employing a home-made single-side 
dip-coating device, and monitored the self-assembly process by testing the zeta potential, contact angle 
and UV-VIS spectrum ofthe membrane surface. 
✓ Investigated the effect of the bilayer number and operation temperature on the separation properties of 
hybrid membranes by measuring the pervaporation performance of GO-based membranes. 
Publication 
✓ Jing Zhao, Chenhao Fang, Yiwei Zhu, et al. Manipulating the interfacial interactions of composite 
membranes via a mussel-inspired approach for enhanced separation selectivity [J]. Journal of Materials 
Chemistry A, 2015, 3(39): 19980-19988. 
✓ Jing Zhao, Yiwei Zhu, Fusheng Pan, Guangwei He, Chenhao Fang, et al. Fabricating graphene oxide-
based ultrathin hybrid membrane for pervaporation dehydration via layer-by-layer self-assembly driven 
by multiple interactions [J]. Journal of Membrane Science, 2015, 487: 162-172. 
✓ Mingshui Yao, Linan Cao, Guolin Hou, Minlan Cai, Jingwei Xiu, Chenhao Fang, et al. Gold–tin co-
sensitized ZnO layered porous nanocrystals: enhanced responses and anti-humidity [J]. RSC Advances, 




Fujian Institute of Research on Structure of Matter, Chinese Academy of Sciences      Jan. 2015-Feb.2015 
Project: Morphology-controlled ZnOSpherical Nanobelt-Flower Arrays and Their Sensing Properties  
Advisor: Maochun Hong Academician 
✓ Designed and selectively synthesized layered basic zinc acetate (LBZA) hierarchical structures with 
different morphologies from zinc acetate dehydrate (ZnAc2 ▪2H2O) and hexamethylenetetramine (HMT) 
by controlling thegrowth conditions. 
✓ Prepared the self-standing LBZA spherical nanobelt-flower arrays films(LBZA-SFF) by immersing the 
silicon wafer substrate vertically in the ZnAc2 and HMT mixed solution for 72h at 95℃, and heated the 
LBZA-SFF for 0.5h at300℃ andthen stabilized at 400℃ for 20 h to obtain the ZnO spherical nanobelt-
flower arrays films(ZnO-SFF). 
✓ Transferred the ZnO-SFF to the insulating Al2O3 substrate and evaluated the sensing properties to benzene 
gas and stability of ZnO-SFF using a home-made experiment setup. 
✓ The introduction of Au decoration can act as a secondary sensitized element on the ZnO surface to greatly 
reduce the negative effect of relative humidity.  
✓ Further studied on the sensing properties to benzene gas of ZnO spherical nanobelt-flower modified 
bycobaltacetate, manganeseacetate and nickel acetate, respectively. 
Skill 
Computer skills: C language, Origin 
Professional skills: XRD, TG-DTA, SEM, FTIR,XPS, AFM,zeta-potential analyzer, elemental analyzer, 
contact angle goniometer, UV-VIS spectrophotometer, NMR, TEM 
 
 
 
 
 
 
 
 
  
 
